Brilliance Isn’t Enough: Why Scientific Leaders Must Learn to Persuade

In biotech boardrooms, the rules have changed. Deep scientific expertise is still the foundation, but it's no longer the differentiator. The CSOs, CMOs, and first-time CEOs who break through today are the ones who can translate complex science into conviction, capital, and action. 

‍

Here's what that shift looks like, and why it matters more in the age of AI.

‍

Read our CEO Bill Holodnak latest Forbes Article.

‍

Read the full article